Search results for "HYPERTENSION"

showing 10 items of 1283 documents

Emotional eating as a mediator between anxiety and cholesterol in population with overweight and hypertension

2016

Although the relationship between cholesterol and mood states (especially anxiety) has been well studied, few researches have included the role of eating styles in this relationship. This study explored the associations among eating styles, negative emotional symptoms, and levels of cholesterol (and other medical variables) in a population with hypertension and overweight or obesity, analyzing the possible mediation mechanisms involved. A cross-sectional study was conducted in 68 adults with hypertension and overweight/obesity, and stepwise multiple regression analysis and mediation analyses were carried out to test the hypothesis that eating styles mediate the relationship between negative…

AdultMale0301 basic medicineMediation (statistics)medicine.medical_specialtyHypercholesterolemiaStatistics as TopicPopulation030204 cardiovascular system & hematologyOverweightHigh cholesterol03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesmedicineHumansAffective SymptomsPsychiatryeducationApplied PsychologyAgededucation.field_of_study030109 nutrition & dieteticsFeeding BehaviorMiddle AgedOverweightEmotional eatingmedicine.diseaseAnxiety DisordersObesityPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesMoodHypertensionAnxietyFemalelipids (amino acids peptides and proteins)medicine.symptomPsychologyClinical psychologyPsychology, Health & Medicine
researchProduct

Epicardial Adipose Tissue Accumulation and Essential Hypertension in Non-Obese Adults

2019

Background and Objectives: Epicardial adipose tissue (EAT) is shown to be an important factor in the development of coronary artery disease, but numerous pathophysiological mechanisms of its action are still only partially understood. There is a lack of studies on its association with different grades of essential hypertension (EH). Therefore, we aimed to evaluate the association between size of EAT depots and the risk of EH taking into account its grade. Materials and Methods: Non-obese adult patients with various cardiovascular diseases were investigated: 157 of them had essential hypertension and 101 did not. Hypertensive patients were assigned to three groups according to the grade of h…

AdultMale0301 basic medicineMedicine (General)medicine.medical_specialtyepicardial fatBlood Pressure030204 cardiovascular system & hematologyEssential hypertensionArticleBody Mass IndexCoronary artery disease03 medical and health sciencesR5-9200302 clinical medicineNon obeseCardiac magnetic resonance imagingInternal medicinegrade of hypertensionmedicineepicardial fat ; primary hypertension ; grade of hypertension ; risk assessment ; adultsadultsHumansAged2. Zero hungermedicine.diagnostic_testAdult patientsbusiness.industryrisk assessmentGeneral MedicineMiddle Agedmedicine.diseasePathophysiology3. Good healthprimary hypertension030104 developmental biologyAdipose TissueEpicardial adipose tissueCardiologyepicardial fat; primary hypertension; grade of hypertension; risk assessment; adultsFemaleEssential HypertensionbusinessPericardiumBody mass indexMedicina
researchProduct

A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer

2021

Aim: To determine a recommended Phase II dose of the oral fluoropyrimidine trifluridine/tipiracil (FTD/TPI) combined with the multi-kinase inhibitor regorafenib (REG) in refractory metastatic colorectal cancer patients. Materials & methods: A conventional 3 + 3 dose finding design was used. FTD/TPI was administered on days 1–5 and 8–12 of a 28-day cycle, REG on days 2–22. Two dose levels were used: FTD/TPI 25 mg/m2 b.i.d. + REG 120 mg/d, then escalated to FTD/TPI 35 mg/m2 b.i.d. + REG 120 mg/d. Results: In total, 12 patients were treated at two dose levels. Three dose-limiting toxicities were observed; all were grade 3 hypertension causally attributed to REG. Recommended Phase II dose …

AdultMale0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyPyrrolidinesMaximum Tolerated DosePyridinesColorectal cancerAdministration OralTrifluridineDrug Administration ScheduleTrifluridine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRefractoryRegorafenibInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineDose escalationHumansResponse Evaluation Criteria in Solid TumorsAgedTipiracilDose-Response Relationship Drugbusiness.industryPhenylurea CompoundsGeneral MedicineMiddle Agedmedicine.diseaseProgression-Free SurvivalDrug Combinations030104 developmental biologyOncologychemistryThird lineDrug Resistance Neoplasm030220 oncology & carcinogenesisHypertensionToxicityFeasibility StudiesFemaleColorectal NeoplasmsbusinessThyminemedicine.drugFuture Oncology
researchProduct

Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects.

2003

Background: There has been an increase in research into the association between angiotensin-converting enzyme (ACE) gene deletion polymorphism and cardiovascular disease, with conflicting results. The present prospective long-term study was conducted to evaluate whether the DD genotype could also be associated with a higher prevalence of hypertension in healthy subjects, over 6 years of follow-up. Methods: Population: 684 healthy volunteers (aged, 25–55 years): normotensive and free of cardiovascular diseases, with acceptable echocardiographic window. All subjects had to have a normal electrocardiogram (ECG) and echocardiogram (ECHO) at entry. Study protocol: All subjects underwent a comple…

AdultMaleACE-I/D gene polymorphismmedicine.medical_specialtyTime FactorsGenotypePopulationBlood PressurePeptidyl-Dipeptidase AReference ValuesInternal medicineMedicineHumansProspective StudiesFamily historyeducationeducation.field_of_studyPolymorphism Geneticbiologybusiness.industryIncidence (epidemiology)IncidenceAngiotensin-converting enzymeVenous bloodMiddle Agedmedicine.diseaseMutagenesis InsertionalEndocrinologyBlood pressureHeart failureHypertensionbiology.proteinFemaleGene polymorphismCardiology and Cardiovascular MedicinebusinessHealthy subjectGene DeletionFollow-Up StudiesEuropean journal of heart failure
researchProduct

Observations of time-based measures of flow-mediated dilation of forearm conduit arteries: implications for the accurate assessment of endothelial fu…

2010

Endothelium-dependent flow-mediated dilation (FMD) is measured as the increase in diameter of a conduit artery in response to reactive hyperemia, assessed either at a fixed time point [usually 60-s post-cuff deflation (FMD60)] or as the maximal dilation during a 5-min continuous, ECG-gated, measurement (FMDmax-cont). Preliminary evidence suggests that the time between reactive hyperemia and peak dilation (time to FMDmax) may provide an additional index of endothelial health. We measured FMDmax-cont, FMD60, and time to FMDmax in 30 young healthy volunteers, 22 healthy middle-aged adults, 16 smokers, 23 patients with hypertension, 40 patients with coronary artery disease, and 22 patients wit…

AdultMaleAdolescentBrachial ArteryEndotheliumPhysiologyCoronary Artery DiseaseElectrical conduitForearmPhysiology (medical)medicineHumanscardiovascular diseasesEnzyme InhibitorsReactive hyperemiaHeart FailureAnalysis of Variancebusiness.industrySmokingMiddle AgedVasodilationNG-Nitroarginine Methyl Estermedicine.anatomical_structureRegional Blood FlowAnesthesiaHypertensionCirculatory systemcardiovascular systemDilation (morphology)FemaleEndothelium VascularCardiology and Cardiovascular MedicinebusinessBlood vesselArteryAmerican Journal of Physiology-Heart and Circulatory Physiology
researchProduct

Treatment of hypertension with a combination of nifedipine and atenolol compared with atenolol alone. Preliminary report.

1988

AdultMaleAdolescentNifedipinebusiness.industryPharmacology toxicologyBlood PressurePharmacologyMiddle AgedAtenololPharmacotherapyNifedipineAtenololPreliminary reportHypertensionmedicineHumansPharmacology (medical)Drug Therapy CombinationFemalebusinessmedicine.drugAgedDrugs
researchProduct

The Effect of Hypertensive Disorders of Pregnancy on the Risk of ADHD in the Offspring

2017

Objective: Evidence suggests that perinatal factors may contribute to the development of ADHD. Our objective was to examine the association between hypertensive disorders of pregnancy (HDP) and ADHD, and behavioral difficulties among 7-year-old children. Method: The study cohort consisted of 13,192 children (weighted = 13,500) who participated in the Millennium Cohort Study (MCS) at age 7. HDP (raised blood pressure, preeclampsia, eclampsia, and toxemia) were reported by mothers 9 months postdelivery. ADHD was reported by parents at age 7 years. Weighted logistic regression models were used to assess the association. Results: In all, 1,069 (7.9%) women reported HDP and 166 (1.2%) children h…

AdultMaleAdolescentOffspringCohort StudiesYoung Adult03 medical and health sciences0302 clinical medicinePregnancyRisk Factorsmental disordersOdds RatioDevelopmental and Educational PsychologymedicineHumans0501 psychology and cognitive sciencesChildAssociation (psychology)Pregnancy05 social sciencesHypertension Pregnancy-Inducedmedicine.diseaseClinical PsychologyLogistic ModelsAttention Deficit Disorder with HyperactivityFemalePsychology030217 neurology & neurosurgery050104 developmental & child psychologyClinical psychologyJournal of Attention Disorders
researchProduct

Evaluation of Hypertension, Proteinuria, and Abnormalities of Body Weight in Italian Adolescents Participating in the World Kidney Days

2020

Introduction: World Kidney Day (WKD) was promoted by the Italian Kidney Foundation and the Italian Society of Nephrology for raising awareness, detection, prevention, and treatment of kidney diseases. The Italian WKD focused on the “School Project” by screening students attending the fifth year of high school. The main goal of the “School Project” was to assess in healthy adolescents the presence of hypertension (HTN) and proteinuria; as well as to evaluate potential interrelations between overweight, obesity (both measured with different anthropometric methods), blood pressure (BP) levels, and proteinuria. The ancillary goal was to have an estimate of awareness on some nephrology topics. M…

AdultMaleAdolescents; Anthropometric indicators; BMI; Hypertension; Obesity; Proteinurialcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyWaistAdolescentAnthropometric indicators · BMI · Proteinuria · Hypertension · Obesity · Adolescents030232 urology & nephrologyOverweightKidneylcsh:RC870-923Young AdultBMI03 medical and health sciencesanthropometric indicators0302 clinical medicineRisk FactorsInternal medicinelcsh:DermatologyAnthropometric indicatormedicineHumansadolescentsObesitycardiovascular diseasesProteinuriabusiness.industryBody WeightGeneral Medicinelcsh:RL1-803Anthropometrylcsh:Diseases of the genitourinary system. Urologymedicine.diseaseObesityBlood pressureItalylcsh:RC666-701NephrologyHypertensionProteinuria.FemaleproteinuriaUnderweightmedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexKidney and Blood Pressure Research
researchProduct

[Cardiac arrhythmias in hypertensive subjects with and without left ventricular hypertrophy compared to the circadian profile of the blood pressure].

1990

To evaluate possible correlations between cardiac arrhythmias and circadian pattern of blood pressure (BP) and of heart rate (HR), we studied 2 groups of 20 males with stable arterial hypertension of mild to moderate entity, with (Group I) or without (Group II) left ventricular hypertrophy (LVH). In patients with LVH the mean age (56 vs 46 years), the duration of the hypertensive state (48.1 vs 15.7 months), the thickening of interventricular septum (IVS; 13.7 vs 9.6 mm) and of the posterior wall of the left ventricle (13.2 vs 9.2 mm) and the mass of LV (149.8 vs 99.7 g/m2) were significantly greater (p less than 0.01). On the contrary, the 2 groups did not show significant differences conc…

AdultMaleAdult Aged Arrhythmias Cardiac/physiopathology* Blood Pressure/physiology* Cardiomegaly/physiopathology* Circadian Rhythm/physiology* Electrocardiography Humans Hypertension/physiopathology* Male Middle Aged LinkOutSettore MED/09 - Medicina InternaArrhythmias CardiacBlood PressureCardiomegalyMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolareCircadian RhythmElectrocardiographyHypertensionHumansAgedCardiologia (Rome, Italy)
researchProduct

Ageing, lifestyle modifications, and cardiovascular disease in developing countries.

2006

Developing countries face the double menace of still prevalent infectious diseases and increasing cardiovascular disease (CVD) with epidemic proportions in the near future, linked to demographic changes (expansion and ageing), and to urbanisation and lifestyle modifications. It is estimated that the elderly population will increase globally (over 80% during the next 25 years), with a large share of this rise in the developing world because of expanding populations. Increasing longevity prolongs the time exposure to risk factors, resulting in a greater probability of CVD. As a paradox, increased longevity due to improved social and economical conditions associated with lifestyle changes in t…

AdultMaleAgingAGEING LIFESTYLE HYPERTENSION DIABETES OBESITY CARDIOVASCULAR DISEASE CHRONIC DISEASESSettore MED/09 - Medicina InternaAdolescentInfant NewbornInfantHealth PromotionEmigration and ImmigrationMiddle AgedLife ExpectancyCardiovascular DiseasesRisk FactorsChild PreschoolHumansFemaleChildPopulation GrowthDeveloping CountriesLife StyleAged
researchProduct